Evidence map›Paper›PMID 42185624›Full record

ArticleCell research2026

Structural basis of the neuronal M-current generated by an asymmetric KCNQ2/3 assembly.

Xinyu Cheng, Shuangyan Wan, Dexiang Jiang, Hangyu Zhang, Bin Hu, Tong Che, Yuanpeng Chen, Weiwei Nan, Zhuo Zhou, Chenxin Xiao and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xinyu Cheng *The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Shuangyan Wan *The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Dexiang Jiang *Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery; State Key Laboratory of Mechanism and Quality of Chinese Medicine; School of Pharmacy, Faculty of Medicine; Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SAR, China.
Hangyu Zhang *Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery; State Key Laboratory of Mechanism and Quality of Chinese Medicine; School of Pharmacy, Faculty of Medicine; Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SAR, China.
Bin Hu *Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, School of Basic Medical Sciences, Gannan Medical University, Ganzhou, Jiangxi, China.
Tong CheThe MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.ORCID http://orcid.org/0009-0000-7871-5688
Yuanpeng ChenThe MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Weiwei NanShenzhen Crystalo Biopharmaceutical Co., Ltd, Shenzhen, Guangdong, China.
Zhuo ZhouDr. Neher's Biophysics Laboratory for Innovative Drug Discovery; State Key Laboratory of Mechanism and Quality of Chinese Medicine; School of Pharmacy, Faculty of Medicine; Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SAR, China.
Chenxin XiaoDr. Neher's Biophysics Laboratory for Innovative Drug Discovery; State Key Laboratory of Mechanism and Quality of Chinese Medicine; School of Pharmacy, Faculty of Medicine; Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SAR, China.
Ling ZhongDr. Neher's Biophysics Laboratory for Innovative Drug Discovery; State Key Laboratory of Mechanism and Quality of Chinese Medicine; School of Pharmacy, Faculty of Medicine; Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SAR, China.
Yuting ZhangShenzhen Crystalo Biopharmaceutical Co., Ltd, Shenzhen, Guangdong, China.
Bing XiongDepartment of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Panpan HouDr. Neher's Biophysics Laboratory for Innovative Drug Discovery; State Key Laboratory of Mechanism and Quality of Chinese Medicine; School of Pharmacy, Faculty of Medicine; Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SAR, China. pphou@must.edu.mo.
Jin ZhangThe MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. zhangxiaokong@hotmail.com.ORCID http://orcid.org/0000-0002-9705-0033

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42185624
PMCPMC13287585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.